Veterinary Medicines

TAbic IB VAR206, effervescent tablets for suspension for chickens

Authorised
  • Avian infectious bronchitis virus, strain 2-06, Live
Download as PDF

Product identification

Medicine name:
TAbic IB VAR206, effervescent tablets for suspension for chickens
TAbic IB VAR206 putojošās tabletes suspensijas pagatavošanai vistām
Active substance:
  • Avian infectious bronchitis virus, strain 2-06, Live
Target species:
  • Chicken (hen)
Route of administration:
  • Nebulisation use

Product details

Active substance and strength:
  • Avian infectious bronchitis virus, strain 2-06, Live
Pharmaceutical form:
  • Effervescent tablet
Withdrawal period by route of administration:
  • Nebulisation use
    • Chicken (hen)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD07
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Available in:
  • Latvia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Phibro Animal Health (Poland) Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Synoptis Industrial Sp. z o.o.
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/MRP/19/0082
Date of authorisation status change:
Reference member state:
  • Poland
Procedure number:
  • PL/V/0109/001/MR
Concerned member states:
  • Bulgaria
  • Czechia
  • Latvia
  • Lithuania
  • Romania
  • Slovakia
  • Slovenia

Documents

Combined File of all Documents

English (PDF)
Published on: 7/02/2024
Download
Latvian (PDF)
Published on: 27/03/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."